Economic assessment of dasatinib: greater validity for Chilean patients

Economic assessment of dasatinib: greater validity for Chilean patients

Bibliographic Details
Main Author:	Gabriela Moreno
Format:	Article
Language:	English
Published:	Medwave Estudios Limitada 2011-05-01
Series:	Medwave
Online Access:	http://dx.doi.org/10.5867/medwave.2011.05.5036

Similar Items

Pharmacokinetics of Dasatinib
by: Jana Hořínková, et al.
Published: (2019-10-01)

Economic evaluation of dasatinib in the treatment of chronic myeloid leukemia patients resistant to imatinib in Chile
by: Milva Caputo, et al.
Published: (2011-04-01)

Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel
by: Araujo JC, et al.
Published: (2013-03-01)

Haemorrhagic Colitis Caused by Dasatinib
by: Nishant Patodi, et al.
Published: (2012-01-01)

DASATINIB IN CHRONIC MYELOID LEUKEMIA
by: Mojca Modic
Published: (2008-04-01)

Efficacy and Tolerability after Unusually Low Doses of Dasatinib in Chronic Myeloid Leukemia Patients Intolerant to Standard-Dose Dasatinib Therapy
by: Mariana Serpa, et al.
Published: (2010-01-01)

Pharmacological control of CAR T-cells by dasatinib
by: Mestermann, Katrin
Published: (2020)

Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia
by: David N. Perdigoto, et al.
Published: (2017-10-01)

Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia
by: Michelle D. Lundholm, et al.
Published: (2020-07-01)

Patient adherence and persistence with Imatinib, Nilotinib, Dasatinib in clinical practice.
by: Fiorenzo Santoleri, et al.
Published: (2013-01-01)

Family Communication Scale: Validation in Chilean
by: Joucelyn Rivadeneira, et al.

Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01)

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
by: Olaf Beck, et al.
Published: (2020-03-01)

An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis
by: Burak Uz, et al.
Published: (2016-01-01)

Dasatinib in chronic myeloid leukemia: a review
by: Dolly G Aguilera, et al.
Published: (2009-03-01)

Systematic review of dasatinib in chronic myeloid leukemia
by: Breccia M, et al.
Published: (2013-03-01)

Dasatinib: ten years of clinical practice worldwide
by: K. M. Abdulkadyrov, et al.
Published: (2016-03-01)

Dasatinib-induced perforating folliculitis in a bone marrow transplant patient
by: Nagendran Prabhakaran, et al.
Published: (2020-01-01)

Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations
by: Keskin D, et al.
Published: (2016-10-01)

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment
by: Tarantini F, et al.
Published: (2019-08-01)

Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency
by: Kelly Airiau, et al.
Published: (2018-06-01)

A validated UPLCâMS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma
by: Jing Zeng, et al.
Published: (2017-12-01)

Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients
by: Roberto Candia, et al.
Published: (2017-09-01)

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
by: Andris Skride, et al.
Published: (2017-12-01)

Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01)

Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity
by: Rhodora C. Calizo, et al.
Published: (2019-05-01)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
by: Ashraf El-Dabh, et al.
Published: (2019-07-01)

Dasatinib Induced Cardiac Tamponade-A Rare Association
by: Sushant Wattal, et al.
Published: (2017-02-01)

Dasatinib-induced hemorrhagic colitis complicated with cytomegalovirus infection
by: Aya Nakaya, et al.
Published: (2017-12-01)

Dasatinib-induced pleural effusion: Chylothorax, an option to consider
by: Lucia Ferreiro, et al.
Published: (2016-01-01)

The role of dasatinib in the management of chronic myeloid leukemia
by: Chen R, et al.
Published: (2015-02-01)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
by: Radhakrishnan Ramchandren, et al.
Published: (2009-05-01)

Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.
by: G Rogers, et al.
Published: (2012-04-01)

Chilean Nutrition Management Protocol for Patients With Phenylketonuria
by: Gabriela Castro, et al.
Published: (2017-02-01)

Validated UPLC-MS/MS method for the quantification of dasatinib in plasma: Application to pharmacokinetic interaction studies with nutraceuticals in Wistar rats.
by: Hadir M Maher, et al.
Published: (2018-01-01)

Dasatinib Induced Avascular Necrosis of Femoral Head in Adult Patient with Chronic Myeloid Leukemia
by: Mohamed A. Yassin, et al.
Published: (2015-01-01)

Dasatinib Induced Avascular Necrosis of Femoral Head in Adult Patient with Chronic Myeloid Leukemia
by: Mohamed A. Yassin, et al.
Published: (2015-07-01)

Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
by: Andrew Stevenson Joel Chandranesan, et al.
Published: (2018-01-01)

Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
by: Monika Conchon, et al.
Published: (2010-01-01)

Validity of the self-reported number of teeth in Chilean adults
by: Paula Margozzini, et al.
Published: (2019-06-01)